Journals Library


HTA - 08/211/01

Bevacizumab in combination with oxaliplatin and either 5-FU or capecitabine for the treatment of metastatic colorectal cancer

Project title: Bevacizumab in combination with oxaliplatin and either 5-FU or capecitabine for the treatment of metastatic colorectal cancer

Call to action: 14/116 NICE 19th Wave STA

Research type: Evidence Synthesis

Chief investigator: Professor Eva KaltenthalerORCID logoorcid.org/0000-0002-6185-8321

Lead Author: Dr Sophie Whyte

Contractor: University of Birmingham

Co-investigators: Dr Sophie Whyte.

Started: July 2009 | Status: Published November 2010

Links to project documentation

The links and documents below are related to this research and are added as and when they are produced over the life of the project. The information is provided by the researchers and some may have undergone varying editorial, production and publication models, which differ to NIHR Journals Library reports. Links are to both internal (NIHR) and external websites – the NIHR is not responsible for the content of external websites.

Background & Research Questions

Why the research is being done and what is being asked

Methods

How the research is being done

Publications & Outputs

What the research produced

Outcomes & Impact

What happened as a result of the research

If you would like to receive a notification when this project is updated, please submit your email address below. This will also notify you when the Journals Library report is published.